Detalhe da pesquisa
1.
Intravenous ferric carboxymaltose for iron repletion following acute heart failure in patients with and without diabetes: a subgroup analysis of the randomized AFFIRM-AHF trial.
Cardiovasc Diabetol
; 22(1): 215, 2023 08 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37592272
2.
Ferric Carboxymaltose in Iron-Deficient Patients with Hospitalized Heart Failure and Reduced Kidney Function.
Clin J Am Soc Nephrol
; 18(9): 1124-1134, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37382961